Cellectis (CLLS) Shares Outstanding (2015 - 2026)
Cellectis (CLLS) recorded Shares Outstanding of 100.28 million in Q2 2026, up 10.7% from 90.57 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Shares Outstanding (2015 - 2026) Analysis & Trends
Starting with Q4 2015, Cellectis' Shares Outstanding history includes 43 quarters.
- Annual Shares Outstanding has increased for ten straight years, with a five-year compound annual growth rate of 18.7% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding came in at 90.57 million in FY2024 (+58.9%), 57.01 million in FY2023 (+25.2%), 45.55 million in FY2022 (+1.6%) and 44.82 million in FY2021 (+5.5%).
- On a year-over-year basis, Shares Outstanding has increased for 11 consecutive quarters, with growth averaging 92.9% over the last eight quarters.
- Peak year-over-year performance for Shares Outstanding in the last five years was growth of 475.4% in Q3 2024, against a decline of 77.9% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 100.28 million (Q1 2026), 100.28 million (Q4 2025) and 90.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Cellectis | 151.51 Mn | -601.88 Mn | - | 100.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.28 Mn |
| Mar 31, 2026 | 100.28 Mn |
| Dec 31, 2025 | 100.28 Mn |
| Sep 30, 2025 | 90.57 Mn |
| Jun 30, 2025 | 90.57 Mn |
| Mar 31, 2025 | 90.57 Mn |
| Dec 31, 2024 | 90.57 Mn |
| Sep 30, 2024 | 57.01 Mn |
| Jun 30, 2024 | 57.01 Mn |
| Mar 31, 2024 | 57.01 Mn |
| Dec 31, 2023 | 57.01 Mn |
| Sep 30, 2023 | 9.91 Mn |
| Jun 30, 2023 | 9.91 Mn |
| Mar 31, 2023 | 45.55 Mn |
| Dec 31, 2022 | 45.55 Mn |
| Sep 30, 2022 | 44.82 Mn |
| Jun 30, 2022 | 44.82 Mn |
| Mar 31, 2022 | 44.82 Mn |
| Dec 31, 2021 | 44.82 Mn |
| Sep 30, 2021 | 42.50 Mn |
API Access
Cellectis Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();